Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000912057-02-032118
Filing Date
2002-08-14
Accepted
2002-08-14 15:59:24
Documents
5
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2086705z10-q.htm 10-Q 186321
3 EXHIBIT 10.1 a2086705zex-10_1.htm EX-10.1 15536
4 EXHIBIT 10.2 a2086705zex-10_2.htm EX-10.2 422305
5 EXHIBIT 10.3 a2086705zex-10_3.htm EX-10.3 8531
6 EXHIBIT 99.1 a2086705zex-99_1.htm EX-99.1 3081
  Complete submission text file 0000912057-02-032118.txt   637713
Mailing Address 2292 FARADAY AVE CARLSBAD CA 92008
Business Address 2292 FARADAY AVE CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 02736429
SIC: 2834 Pharmaceutical Preparations